Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1954 Oct 31;100(5):451–471. doi: 10.1084/jem.100.5.451

A STUDY OF THE CHEMICAL NATURE OF COMPONENTS OF BOVINE WHITE MATTER EFFECTIVE IN PRODUCING ALLERGIC ENCEPHALOMYELITIS IN THE RABBIT

Byron H Waksman 1, Huntington Porter 1, Marjorie D Lees 1, Raymond D Adams 1, Jordi Folch 1
PMCID: PMC2136392  PMID: 13211907

Abstract

Fractions of bovine white matter, prepared by the methods of Folch and Lees, were studied for chemical composition and for their ability to produce experimental allergic encephalomyelitis in rabbits. Evaluation of the disease and of the lesions in animals injected with the more active fractions at several dose levels permitted comparison of the antigenic activity of these materials. When tissue was fractionated by the methods of Folch and Lees, antigenic activity was found in the chloroform-methanol extract but not in the denatured tissue residue. This activity was traced to proteolipides A and B and to the lower phase, more specifically the ether-soluble fraction of the lower phase. Proteolipide C was inactive. Correlation of the chemistry of fractions with their antigenic activity suggested two possibilities: (a) that there might be two antigens, one proteolipide and the other non-proteolipide; or (b) that a small specific proteolipide is responsible for all the observed activity. The high concentration of acetal phosphatide in the ether-soluble lower phase suggested that compounds of this type might be the hypothetical non-proteolipide antigen, but this hypothesis was disproved by analytic study of active and inactive materials. The possibility that proteolipide might account for all the antigenic activity was strongly supported by the experimental finding that total lipide and proteolipide progressively lost activity as proteolipide was degraded by adequate processing. The use of an entirely different method for preparing total lipides free of proteolipide (the colloidal iron technique) indicated that this loss of activity did not result from incidental removal of some non-proteolipide antigen. These tentative conclusions are in agreement with those of Tal and Olitsky and provide a satisfactory interpretation of the findings of Goldstein et al. The very fact, however, that the suggested proteolipide antigen would amount to no more than 1 per cent of the total chloroform-methanol extractives leaves open the possibility that some unrecognized trace substance may be the antigen. Skin tests with the various fractions indicated some cross-reactivity between proteolipides A and B and the ether-soluble lower phase fraction and a fair correlation of positive skin reactions with disease. This finding is compatible with the suggestion that the same antigen is present in both of these types of material. When the disease produced by whole tissue or fractions was evaluated by the use of the proportion of animals developing disease, the day of onset, and the severity of the histologic lesions, it was found that fractions produced milder disease of later onset than intact tissue at all dose levels. The disease-producing activity was not enhanced by increasing the dose; i.e., it appeared to reach an asymptotic maximum below that obtainable with whole fresh tissue. This finding suggests both a quantitative loss of activity and a qualitative change during the initial chloroform-methanol extraction, a procedure which denatures all proteins in the tissue residue. A comparable change appeared to occur in whole white matter stored at –15°C. for 15 months and thawed and refrozen several times during this period. The later fractionation steps resulted in no apparent loss of antigenic activity. A scoring method employing the same type of data to estimate the actual relative antigen contents of different preparations is presented in the Appendix.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALVORD E. C., Jr Studies on the etiology and pathogenesis of experimental meningoencephalomyelitis in the guinea pig. J Immunol. 1949 Apr;61(4):355–367. [PubMed] [Google Scholar]
  2. FERRARO A., ROIZIN L. Production of experimental encephalomyelitis with calcium acetate compound extracted from brain tissue. J Neuropathol Clin Neurol. 1951 Oct;10(4):394–407. doi: 10.1097/00005072-195110000-00004. [DOI] [PubMed] [Google Scholar]
  3. FOLCH J., ASCOLI I., LEES M., MEATH J. A., LeBARON N. Preparation of lipide extracts from brain tissue. J Biol Chem. 1951 Aug;191(2):833–841. [PubMed] [Google Scholar]
  4. FOLCH J., LEES M. Proteolipides, a new type of tissue lipoproteins; their isolation from brain. J Biol Chem. 1951 Aug;191(2):807–817. [PubMed] [Google Scholar]
  5. GOLDSTEIN N. P., KOLB L. C., MASON H. L., SAYRE G. P., KARLSON A. G. Relationship of homologous brain proteolipid to allergic encephalomyelitis in guinea pigs. Neurology. 1953 Aug;3(8):609–614. doi: 10.1212/wnl.3.8.609. [DOI] [PubMed] [Google Scholar]
  6. HOTTLE G. A., NEDZEL G. A. Allergic encephalitis following injection of dialysate of brain tissue. Proc Soc Exp Biol Med. 1949 Nov;72(2):289–291. doi: 10.3181/00379727-72-17410. [DOI] [PubMed] [Google Scholar]
  7. HURST E. W. Experimental demyelination in relation to human and animal disease. Am J Med. 1952 May;12(5):547–560. doi: 10.1016/0002-9343(52)90235-0. [DOI] [PubMed] [Google Scholar]
  8. KABAT E. A., WOLF A., BEZER A. E. Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. J Exp Med. 1948 Oct 1;88(4):417–426. doi: 10.1084/jem.88.4.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KOLB L. C. The relationship of the demyelinating diseases to allergic encephalomyelitis. Medicine (Baltimore) 1950 May;29(2):99–121. doi: 10.1097/00005792-195005000-00001. [DOI] [PubMed] [Google Scholar]
  10. Kabat E. A., Wolf A., Bezer A. E. THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS. J Exp Med. 1947 Jan 1;85(1):117–130. doi: 10.1084/jem.85.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morgan I. M. ALLERGIC ENCEPHALOMYELITIS IN MONKEYS IN RESPONSE TO INJECTION OF NORMAL MONKEY NERVOUS TISSUE. J Exp Med. 1947 Jan 1;85(1):131–140. doi: 10.1084/jem.85.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. OLITSKY P. K., TAL C. Acute disseminated encephalomyelitis produced in mice by brain proteolipide (Folch-Lees). Proc Soc Exp Biol Med. 1952 Jan;79(1):50–53. doi: 10.3181/00379727-79-19269. [DOI] [PubMed] [Google Scholar]
  13. OLITSKY P. K., TAL C. Certain properties of the causal agent of experimental disseminated encephalomyelitis in mice. Proc Soc Exp Biol Med. 1951 Nov;78(2):607–610. doi: 10.3181/00379727-78-19155. [DOI] [PubMed] [Google Scholar]
  14. OLITSKY P. K., YAGER R. H. Experimental disseminated encephalomyelitis in white mice. J Exp Med. 1949 Sep;90(3):213–224. doi: 10.1084/jem.90.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. TAL C., OLITSKY P. K. Quantitative studies on proteolipide as incitant of disseminated encephalomyelitis in mice. Science. 1952 Oct 17;116(3016):420–421. doi: 10.1126/science.116.3016.420. [DOI] [PubMed] [Google Scholar]
  16. TAL C., OLITSKY P. K. Quantitative studies on proteolipide as incitant of disseminated encephalomyelitis in mice. Science. 1952 Oct 17;116(3016):420–421. doi: 10.1126/science.116.3016.420. [DOI] [PubMed] [Google Scholar]
  17. TAL C., OLITSKY P. K. The chemical nature of encephalitogenic proteolipide A and B. Proc Soc Exp Biol Med. 1952 Dec;81(3):590–593. doi: 10.3181/00379727-81-19951. [DOI] [PubMed] [Google Scholar]
  18. THANNHAUSER S. J., BONCODDO N. F., SCHMIDT G. Studies of acetal phospholipides of brain. I. Procedure of isolation of crystallized acetal phospholipide from brain. J Biol Chem. 1951 Jan;188(1):417–421. [PubMed] [Google Scholar]
  19. THOMAS A. K. Studies on rabies. VII. Observations on the paralytogenic factor in rabies vaccine. Indian J Med Res. 1952 Jan;40(1):121–129. [PubMed] [Google Scholar]
  20. THOMAS L., PATERSON P. Y., SMITHWICK B. Acute disseminated encephalomyelitis following immunization with homologous brain extracts; studies on the role of a circulating antibody in the production of the condition in dogs. J Exp Med. 1950 Aug;92(2):133–152. doi: 10.1084/jem.92.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. WAKSMAN B. H., MORRISON L. R. Tuberculin type sensitivity to spinal cord antigen in rabbits with isoallergic encephalomyelitis. J Immunol. 1951 Apr;66(4):421–444. [PubMed] [Google Scholar]
  22. Weil A. J. THE WASSERMANN ANTIGEN AND RELATED "ALCOHOL-SOLUBLE" ANTIGENS. Bacteriol Rev. 1941 Dec;5(4):293–330. doi: 10.1128/br.5.4.293-330.1941. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES